Researchers at The University of Texas Southwestern Medical Center have discovered that a drug approved by the U.S. Food and Drug Administration (FDA) may significantly reduce graft-versus-host disease - a potentially life-threatening complication of stem cell transplants. The findings have been published online in the journal Biology of Blood and Marrow Transplantation....
Read More...
[Source: Society News]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment